Oversold

ZLAB

Same as last week
Valuation50/ 100
Cash flow & growth51/ 100
Upside potential38/ 100
Risk potential51/ 100

ZLAB's valuation appears fair, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +5.1%, operating margin -1 percentage points. The business score is 50.7/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Business trends and outlook support upside. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 30.8% upside, or about $31.58.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

The 50.6% downside is driven by operating stress: the model assumes earnings fall 28.6% and the PE falls 30.7%. That gives lower earnings at a lower valuation, or about the scenario price. Price swings alone suggest 42.7% downside.

This is a scenario based on our model, not a forecast or probability.

ZLAB vs Historical averages

MetricCurrentAverageRelative
EPS-$1.79-$35.98$34.19 higher
FCF-$162.5M-$316M+$153.5M
Loading historical comparisons…

ZLAB’s earnings are above their historical averages.

ZLAB Forward outlook

MetricOutlook
Forward valuation--
Forward earningsLoss widening
Forward revenueStable
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionWide

ZLAB’s outlook is weakening, with weaker expected earnings weighing on the picture.

ZLAB PE Valuation

Loading pe valuation table…

This table applies ZLAB's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

ZLAB Earnings Per Share

Loading earnings per share…

This chart tracks ZLAB's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

ZLAB Quarterly Revenue

Loading quarterly revenue…

This chart tracks ZLAB's quarterly revenue over time and shows how sales are changing from year to year.

ZLAB Free Cash Flow

Loading free cash flow…

This chart tracks ZLAB's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

ZLAB Total Shares

Loading shares over time…

This chart tracks changes in ZLAB's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

ZLAB Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

ZLAB PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares ZLAB's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

ZLAB Weekly Price

Loading weekly price…

This chart uses ZLAB's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

ZLAB Weekly Moving Averages

Loading weekly moving averages…

This chart compares ZLAB's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

ZLAB Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.